Enable AccessibilityEnable Accessibility

TAKEDA SUPPORTS ILLINOIS BICENTENNIAL STEM FUSION PROGRAM

May 24, 2018

Funds to support the Illinois Math and Science Academy’s (IMSA) renowned teacher development training initiative for math and science.

 

 

DEERFIELD, ILL., May 23, 2018 –  Takeda is proud to support Illinois Governor Bruce Rauner’s three-year Bicentennial STEM Fusion Program, launched earlier this week.

Gov. Rauner announced that 25 Illinois elementary and middle schools have been awarded a three-year Bicentennial STEM Fusion Program, The Governor revealed the list of awardees during a visit to one of the recipients, Dubois Elementary School in Springfield. Lt. Gov. Evelyn Sanguinetti made a parallel visit to Peck Elementary School, an awardee in Chicago.

IMSA Fusion is a teacher professional development and student STEM (science, technology, engineering and math) enrichment program for Illinois students who are talented, interested and motivated but underrepresented in mathematics, science, and technology. The program focuses on teachers and students in grades 4-8 and hopes to stimulate STEM careers.  

Richard Ascroft, Senior Vice President of Government and External Affairs at Takeda said of the sponsorship:

“As part of our corporate giving program, Takeda Cares, we support a number of early education STEM initiatives. We are thrilled for the opportunity to support the Bicentennial here in Illinois, and do our part to prepare the next generation of innovators for careers in the knowledge economy.”

More than 100 schools applied for the 25 Fusion programs made available through the Bicentennial. The 25 schools selected serve predominately underserved populations who demonstrated a commitment to embedding IMSA Fusion into their curriculum and presented a sustainability plan to carry the program forward after the three-year award period expires. STEM training is considered critical to work in the future. Seventy other qualifying schools will receive a one-year curriculum.

The 25 awarded schools are:

  • Akin CCSD 91 – Akin
  • Arthur Dixon Elementary School – Chicago
  • Barack Obama School of Leadership and STEM – Chicago Heights
  • Bernard Long Elementary School – Madison
  • Booker T. Washington STEM Academy – Champaign
  • Brown County Middle School – Mt. Sterling
  • Dallas City Elementary School – Dallas City
  • Dubois Elementary – Springfield
  • Earle STEM Elementary School – Chicago
  • Frazier International Magnet School – Chicago
  • Galva Junior Senior School – Galva
  • Garrison School – Jacksonville
  • Gifford Grade School – Gifford
  • Herrin Junior High School - Herrin
  • Kimball Hill Elementary School – Rolling Meadows
  • LEARN 10 – North Chicago
  • LEARN 6 – North Chicago
  • Mozart Elementary School – Chicago
  • Murray Language Academy – Chicago
  • North Ridge Middle School – Danville
  • Peck Elementary School – Chicago
  • Pikeland Community School – Pittsfield
  • San Miguel School – Chicago
  • Whittier Primary School – Peoria
  • Windsor Elementary – Loves Park

About Illinois Math and Science Academy

The internationally recognized Illinois Mathematics and Science Academy (IMSA) develops creative, ethical leaders in science, technology, engineering and mathematics. As a teaching and learning laboratory created by the State of Illinois, IMSA enrolls academically talented Illinois students (grades 10-12) in its advanced, residential college preparatory program, and it serves thousands of educators and students in Illinois and beyond through innovative instructional programs that foster imagination and inquiry.  IMSA Fusion is a teacher professional development and student STEM enrichment program for Illinois students who are talented, interested and motivated in mathematics and science. IMSA Fusion places a special emphasis on students who are historically underrepresented in those areas. Fusion works with teachers and students in grades 4-8.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and neuroscience therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. Innovative products, especially in oncology and gastroenterology, as well as Takeda’s presence in emerging markets, are currently fueling the growth of Takeda. Around 30,000 Takeda employees are committed to improving quality of life for patients, working with Takeda’s partners in health care in more than 70 countries. For more information, visit https://www.takeda.com/newsroom/.

Takeda Pharmaceuticals U.S.A., Inc. is located in Deerfield, Ill., and is the U.S. marketing and sales organization of Takeda Pharmaceutical Company Limited.

Additional information about Takeda is available through its corporate website, www.takeda.com, and additional information about Takeda Pharmaceuticals U.S.A., Inc. is available through its website, www.takeda.us.

Contact:

Justine Grosvenor                                                     
Takeda Pharmaceuticals U.S.A., Inc.                                                        
Tel: 224-554-1583
[email protected]